# Edwards Lifesciences (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/edwards-lifesciences-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 84 |
| Citations | 155,077 |
| City | Irvine |
| Country | US |
| Description | Edwards Lifesciences (United States) is a research organisation in Irvine, US. OpenAlex records 1,143 works and 155,077 citations for it. 350 researchers list it as their most recent affiliation. |
| Homepage | http://www.edwards.com/ |
| OpenAlex ID | https://openalex.org/I4210155533 |
| Region | California |
| Researchers | 350 |
| ROR ID | https://ror.org/04jhyte11 |
| Type | company |
| Works | 1,143 |

## University papers

- [ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article](https://scholariq.org/papers/acc-aha-scai-2005-guideline-update-for-percutaneous-coronary-intervention/)
- [2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention](https://scholariq.org/papers/2007-focused-update-of-the-acc-aha-scai-2005-guideline-update-for-percutaneous/)
- [Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II](https://scholariq.org/papers/anatomical-and-clinical-characteristics-to-guide-decision-making-between/)
- [Assessment of the SYNTAX score in the Syntax study](https://scholariq.org/papers/assessment-of-the-syntax-score-in-the-syntax-study/)
- [1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification](https://scholariq.org/papers/1-year-outcomes-of-transcatheter-mitral-valve-replacement-in-patients-with/)
- [The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin](https://scholariq.org/papers/the-plasminogen-activator-inhibitor-pai-1-controls-in-vivo-tumor-vascularization/)
- [Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification](https://scholariq.org/papers/transcatheter-mitral-valve-replacement-in-native-mitral-valve-disease-with/)
- [Thirty-Day Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Valve-in-Valve), Failed Surgical Rings (Valve-in-Ring), and Native Valve With Severe Mitral Annular Calcification (Valve-in-Mitral Annular Calcification) in the United States](https://scholariq.org/papers/thirty-day-outcomes-of-transcatheter-mitral-valve-replacement-for-degenerated/)

## University top topics

Showing 8 of 25.

- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Aortic Disease and Treatment Approaches](https://scholariq.org/topics/aortic-disease-and-treatment-approaches/)
- [Infective Endocarditis Diagnosis and Management](https://scholariq.org/topics/infective-endocarditis-diagnosis-and-management/)
- [Congenital Heart Disease Studies](https://scholariq.org/topics/congenital-heart-disease-studies/)
- [Hemodynamic Monitoring and Therapy](https://scholariq.org/topics/hemodynamic-monitoring-and-therapy/)
- [Cardiac, Anesthesia and Surgical Outcomes](https://scholariq.org/topics/cardiac-anesthesia-and-surgical-outcomes/)
- [Pulmonary Hypertension Research and Treatments](https://scholariq.org/topics/pulmonary-hypertension-research-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.